Answers are grounded in this paper and cite their sources.
Aims Endoscopic resection is widely accepted as a local treatment for rectal neuroendocrine tumors (NETs) sized≤10 mm. However, there is no consensus on the best method for the endoscopic resection of rectal NETs. As a simplified endoscopic procedure, endoscopic submucosal resection with a ligation device (ESMR-L) indicates a histologically complete resection rate comparable to that of endoscopic submucosal dissection (ESD). However, existing data are based on retrospective studies, and no multicenter randomized controlled trials have directly compared these two techniques. Given the procedural simplicity of ESMR-L, we hypothesized that ESMR-L than ESD would be preferred for rectal NETs. Hence, this trial aimed to verify whether ESMR-L is non-inferior to ESD in terms of histologically complete resection rate [ 1 ]. Methods This was a prospective, open-label, multicenter, non-inferiority, randomized controlled trial of two parallel groups, conducted at 32 institutions in Japan. 1 Patients with a lesion endoscopically diagnosed as a rectal NET≤10 mm were eligible for inclusion. Patients were randomized to undergo either ESD or ESMR-L. Adjustment factors were participating institutions and endoscopist expertise levels (expert or non-expert). Expert endoscopists were defined as those with experience in>40 colorectal ESD procedures. The primary endpoint was the rate of en bloc resection with histologically tumor-free margins (R0 resection). Secondary endpoints included en bloc resection rate, procedure time, hospital stay, total devices and agents cost, and adverse events. Assuming R0 resection rates of 95.2% (ESD) and 95.3% (ESMR-L), with a non-inferiority margin of 8%, one-sided α of 0.05, power of 80%, and dropout rate of 15%, the required sample size was 266 patients. Results Of 266 enrolled patients, 135 and 131 were allocated to the ESD and ESMR-L groups, respectively. After excluding non-neoplastic lesions, 130 and 127 patients were included in the main analysis. A total of 93 endoscopists participated in the study, including 60 experts and 33 non-experts. Baseline characteristics, including age, sex, performance status, antithrombotic use, and lesion location, were comparable between groups. The mean tumor diameter was 5.4 mm in both groups. R0 resection rates were 92.3% (ESD) and 96.9% (ESMR-L), with a risk difference of 4.5% (two-sided 90% CI,−0.1 to 9.7%), confirming non-inferiority of ESMR-L to ESD (Farrington–Manning test; P<0.001). Subgroup analyses based on the randomization stratification factor (expert vs. non-expert endoscopists) consistently showed a tendency toward a higher R0 resection rate in the ESMR-L group (expert: 3.2% [−1.8 to 8.7%], non-expert: 8.0% [−4.0 to 20.7%]). En bloc resection was achieved in all cases. The mean procedure time, hospital stay, and total device cost were significantly lower in the ESMR-L group (28.0 vs. 5.2 min; 4.4 vs. 3.4 days; 51,102 JPY vs. 24,382 JPY; all P<0.001). Postoperative bleeding occurred in 3 (2.2%) and 5 (3.8%) patients in the ESD and ESMR-L groups, respectively (P=0.496), with no perforations observed. Conclusions For rectal NETs≤10 mm, ESMR-L demonstrated non-inferior R0 resection rates compared with ESD and offered advantages of shorter procedure time, reduced hospitalization, and lower cost. These findings support ESMR-L as a simpler and more cost-effective standard treatment option. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Hirasawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: